Gilead Sciences (GILD) Gains from Investment Securities (2009 - 2026)
Gilead Sciences posted quarterly Gains from Investment Securities of $17.0 million for Q1 2026, up 103.99% year-on-year from $8.3 million in Q1 2025, and up 254.55% on a QoQ basis from -$11.0 million in Q4 2025.
Gilead Sciences (GILD) has 18 years of Gains from Investment Securities data on file, last reported at $17.0 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 103.99% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2026 stood at $441.0 million (up 192.07% YoY), and the FY2025 full-year result was -$2.0 million, up 96.55% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $17.0 million, up from -$11.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $661.0 million in Q3 2024 and bottomed at -$640.0 million in Q3 2022.
- The 5-year median for Gains from Investment Securities is -$19.5 million (2025), against an average of -$16.1 million.
- The widest annual swing landed in 2023, when Gains from Investment Securities soared 824.59%; it then plunged 8420.0% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$61.0 million in 2022, then jumped by 824.59% to $442.0 million in 2023, then sank by 215.61% to -$511.0 million in 2024, then soared by 97.85% to -$11.0 million in 2025, then soared by 254.55% to $17.0 million in 2026.
- The last three Gains from Investment Securities figures came in at $17.0 million (Q1 2026), -$11.0 million (Q4 2025), and -$28.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.00 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -28.00 Mn |
| Sep 30, 2025 | -28.00 Mn |
| Jun 30, 2025 | 463.00 Mn |
| Jun 30, 2025 | 463.00 Mn |
| Mar 31, 2025 | -426.00 Mn |
| Mar 31, 2025 | -426.00 Mn |
| Dec 31, 2024 | -511.00 Mn |
| Dec 31, 2024 | -511.00 Mn |
| Sep 30, 2024 | 661.00 Mn |
| Sep 30, 2024 | 661.00 Mn |
| Jun 30, 2024 | -203.00 Mn |
| Jun 30, 2024 | -203.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | 442.00 Mn |
| Dec 31, 2023 | 442.00 Mn |
| Sep 30, 2023 | 205.00 Mn |
| Sep 30, 2023 | 205.00 Mn |
| Jun 30, 2023 | -142.00 Mn |
| Jun 30, 2023 | -142.00 Mn |
| Mar 31, 2023 | -63.00 Mn |
| Mar 31, 2023 | -63.00 Mn |
| Dec 31, 2022 | -61.00 Mn |
| Dec 31, 2022 | -61.00 Mn |
| Sep 30, 2022 | -640.00 Mn |
| Sep 30, 2022 | -640.00 Mn |
| Jun 30, 2022 | 44.00 Mn |
| Jun 30, 2022 | 44.00 Mn |
| Dec 31, 2021 | 399.00 Mn |
| Dec 31, 2021 | 399.00 Mn |
| Sep 30, 2021 | -142.00 Mn |
| Sep 30, 2021 | -142.00 Mn |
| Jun 30, 2021 | 174.00 Mn |
| Jun 30, 2021 | 174.00 Mn |
| Mar 31, 2021 | 91.00 Mn |
| Mar 31, 2021 | 91.00 Mn |
| Dec 31, 2020 | -1.73 Bn |
| Dec 31, 2020 | -1.73 Bn |
| Sep 30, 2020 | -964.00 Mn |
| Sep 30, 2020 | -964.00 Mn |
| Jun 30, 2020 | 201.00 Mn |
| Jun 30, 2020 | 201.00 Mn |
| Mar 31, 2020 | 8.00 Mn |
| Mar 31, 2020 | 8.00 Mn |
| Dec 31, 2019 | 929.00 Mn |
| Dec 31, 2019 | 929.00 Mn |
| Sep 30, 2019 | 99.00 Mn |
| Sep 30, 2019 | 99.00 Mn |
| Jun 30, 2019 | 253.00 Mn |
| Jun 30, 2019 | 253.00 Mn |
| Mar 31, 2019 | -40.00 Mn |
| Mar 31, 2019 | -40.00 Mn |
| Dec 31, 2018 | 182.00 Mn |
| Dec 31, 2018 | 182.00 Mn |
| Sep 30, 2018 | 27.00 Mn |
| Sep 30, 2018 | 27.00 Mn |
| Jun 30, 2018 | 30.00 Mn |
| Jun 30, 2018 | 30.00 Mn |
| Mar 31, 2018 | -49.00 Mn |
| Mar 31, 2018 | -49.00 Mn |
| Dec 31, 2017 | -77.00 Mn |
| Dec 31, 2017 | -77.00 Mn |
| Sep 30, 2017 | -38.00 Mn |
| Sep 30, 2017 | -38.00 Mn |
| Jun 30, 2017 | -150.00 Mn |
| Jun 30, 2017 | -150.00 Mn |
| Mar 31, 2017 | -39.00 Mn |
| Mar 31, 2017 | -39.00 Mn |
| Dec 31, 2016 | -20.00 Mn |
| Dec 31, 2016 | -20.00 Mn |
| Sep 30, 2016 | -24.00 Mn |
| Sep 30, 2016 | -24.00 Mn |
| Jun 30, 2016 | -50.00 Mn |
| Jun 30, 2016 | -50.00 Mn |
| Mar 31, 2016 | -68.00 Mn |
| Mar 31, 2016 | -68.00 Mn |
| Dec 31, 2015 | -528.00 Mn |
| Dec 31, 2015 | -528.00 Mn |
| Sep 30, 2015 | -7.00 Mn |
| Sep 30, 2015 | -7.00 Mn |
| Jun 30, 2015 | -30.00 Mn |
| Jun 30, 2015 | -30.00 Mn |
| Mar 31, 2015 | 3.00 Mn |
| Mar 31, 2015 | 3.00 Mn |
| Dec 31, 2014 | 69.00 Mn |
| Dec 31, 2014 | 69.00 Mn |
| Sep 30, 2014 | -22.00 Mn |
| Sep 30, 2014 | -22.00 Mn |
| Jun 30, 2014 | -32.00 Mn |
| Jun 30, 2014 | -32.00 Mn |
| Mar 31, 2014 | 3.00 Mn |
| Mar 31, 2014 | 3.00 Mn |
| Dec 31, 2013 | 45.12 Mn |
| Dec 31, 2013 | 45.12 Mn |
| Sep 30, 2013 | -18.46 Mn |
| Sep 30, 2013 | -18.46 Mn |
| Jun 30, 2013 | -18.39 Mn |
| Jun 30, 2013 | -18.39 Mn |
| Mar 31, 2013 | -8.26 Mn |
| Mar 31, 2013 | -8.26 Mn |
| Sep 30, 2012 | 26.06 Mn |
| Sep 30, 2012 | 26.06 Mn |
| Jun 30, 2012 | -26.06 Mn |
| Jun 30, 2012 | -26.06 Mn |
| Mar 31, 2012 | 25.00 Mn |
| Mar 31, 2012 | 25.00 Mn |
| Sep 30, 2011 | 6.15 Mn |
| Sep 30, 2011 | 6.15 Mn |
| Jun 30, 2011 | -13.40 Mn |
| Jun 30, 2011 | -13.40 Mn |
| Mar 31, 2011 | 7.25 Mn |
| Mar 31, 2011 | 7.25 Mn |
| Dec 31, 2010 | 9.21 Mn |
| Dec 31, 2010 | 9.21 Mn |
| Sep 30, 2010 | -23.30 Mn |
| Sep 30, 2010 | -23.30 Mn |
| Jun 30, 2010 | -13.65 Mn |
| Jun 30, 2010 | -13.65 Mn |
| Mar 31, 2010 | 2.46 Mn |
| Mar 31, 2010 | 2.46 Mn |
| Dec 31, 2009 | -34.62 Mn |
| Dec 31, 2009 | -34.62 Mn |
| Sep 30, 2009 | 71.09 Mn |
| Sep 30, 2009 | 71.09 Mn |
| Jun 30, 2009 | -14.32 Mn |
| Jun 30, 2009 | -14.32 Mn |
| Mar 31, 2009 | 39.37 Mn |
| Mar 31, 2009 | 39.37 Mn |